FGL2 and neoplasm: The decreased tumor size in Fgl2–/– mice compared with WT mice was commensurate with an increased frequency of tumor-specific OT-I CD8+ T cells at the tumor (Figure 1, F and G) and spleen (Figure 1H) on day 14 after tumor implantation.